AbCellera Biologics Inc. (ABCL) vs Telix Pharmaceuticals Limited (TLX)
AbCellera Biologics Inc. and Telix Pharmaceuticals Limited are both Biotechnology companies. AbCellera Biologics Inc. and Telix Pharmaceuticals Limited are of similar size ($4.2B and $3.9B). Across the 9 metrics below, Telix Pharmaceuticals Limited leads on 5 and AbCellera Biologics Inc. on 4.
Valuation
Profitability
| Metric | ABCL | TLX | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | — | 65.16% |
| Operating margin | (340.25%) | — | 0.00% |
| Net margin | (248.82%) | — | 0.00% |
| Free cash flow margin | (180.84%) | 0.00% | 0.00% |
| Return on equity | (17.30%) | 0.00% | (57.72%) |
| Return on assets | (12.15%) | 0.00% | (49.22%) |
| Return on invested capital | (42.52%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack